A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

Status:	Completed
Conditions:	Cancer, Cancer, Pancreatic Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	Any
Updated:	4/21/2016
Start Date:	January 2014
End Date:	April 2015

MPACT Extension Study: Multicenter, Survival Data Collection in Subjects Previously Enrolled in Protocol CA046

A study to collect survival data on patients previously enrolled in Abraxane pancreatic
cancer study CA046.

A study to collect survival status of CA046 subjects who were know to be alive at the last
report of vital status for CA046 - approximate timeframe - end of March, 2013. Once consent
is given, on a quarterly basis, information on status will be collected to include:

- Vital Status

- Date of disease progression

- Subsequent anticancer therapy for pancreatic adenocarcinoma

Inclusion Criteria:

- Must have been enrolled in the CA046 study Must have been living at the time of the
last survival follow-up (approximate timeframe - end of March, 2013) Must understand
and be able to give informed consent (if a subject is deceased, proper legal consent
(ie, next of kin, legal representative) will be obtained prior to collection of data)

Exclusion Criteria:

- Consent refused for any reason

We found this trial at

sites

Tennessee Oncology, PLLC

250 25th Ave N, Ste 100
Nashville, Tennessee 37023

615-320-5090